Carol David

2.6k total citations
18 papers, 2.1k citations indexed

About

Carol David is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Carol David has authored 18 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cell Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Carol David's work include Cellular transport and secretion (9 papers), Receptor Mechanisms and Signaling (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Carol David is often cited by papers focused on Cellular transport and secretion (9 papers), Receptor Mechanisms and Signaling (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Carol David collaborates with scholars based in United States, Israel and Sweden. Carol David's co-authors include Pietro De Camilli, Detlev Grabs, Peter S. McPherson, Olaf Mundigl, Vladimir I. Slepnev, Xiaomei Zhang, Elizabeth P. Garcia, Yasuo Nemoto, Rudolf Bauerfeind and Michele Solimena and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Carol David

18 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol David United States 14 1.6k 1.5k 607 314 196 18 2.1k
Mary A. Bittner United States 23 1.5k 0.9× 1.0k 0.7× 554 0.9× 243 0.8× 200 1.0× 37 2.0k
Yasuo Nemoto Japan 16 1.8k 1.1× 1.8k 1.2× 655 1.1× 331 1.1× 396 2.0× 22 2.6k
Detlev Grabs Canada 18 1.5k 0.9× 1.4k 1.0× 607 1.0× 315 1.0× 91 0.5× 38 2.1k
Bettina Winckler United States 28 1.3k 0.8× 1.2k 0.8× 949 1.6× 347 1.1× 120 0.6× 56 2.3k
M F Bader France 25 1.4k 0.9× 917 0.6× 520 0.9× 243 0.8× 93 0.5× 34 1.9k
Sergey V. Voronov United States 8 1.4k 0.9× 607 0.4× 409 0.7× 326 1.0× 156 0.8× 8 1.9k
Lambert Edelmann United States 11 1.3k 0.8× 1.2k 0.8× 721 1.2× 306 1.0× 298 1.5× 11 1.9k
Francesca Navone Italy 17 1.5k 0.9× 1.5k 1.0× 868 1.4× 284 0.9× 324 1.7× 26 2.5k
Mikhail Khvotchev United States 22 1.4k 0.9× 1.2k 0.8× 677 1.1× 255 0.8× 77 0.4× 27 2.0k
Phebe S. Wulf Netherlands 20 1.6k 1.0× 1.8k 1.2× 778 1.3× 234 0.7× 97 0.5× 24 2.8k

Countries citing papers authored by Carol David

Since Specialization
Citations

This map shows the geographic impact of Carol David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol David more than expected).

Fields of papers citing papers by Carol David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol David. The network helps show where Carol David may publish in the future.

Co-authorship network of co-authors of Carol David

This figure shows the co-authorship network connecting the top 25 collaborators of Carol David. A scholar is included among the top collaborators of Carol David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol David. Carol David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Baruch, Kuti, et al.. (2020). IBC‐Ab002, an anti‐PD‐L1 monoclonal antibody tailored for treating Alzheimer’s disease. Alzheimer s & Dementia. 16(S9). 2 indexed citations
2.
Mundigl, Olaf, et al.. (1998). Amphiphysin I Antisense Oligonucleotides Inhibit Neurite Outgrowth in Cultured Hippocampal Neurons. Journal of Neuroscience. 18(1). 93–103. 88 indexed citations
3.
Floyd, Scott, Margaret H. Butler, Ottavio Cremona, et al.. (1998). Expression of Amphiphysin I, an Autoantigen of Paraneoplastic Neurological Syndromes, in Breast Cancer. Molecular Medicine. 4(1). 29–39. 57 indexed citations
4.
Schmierer, Klaus, et al.. (1998). Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression. Neurology. 51(1). 250–252. 26 indexed citations
5.
Shupliakov, Oleg, Péter Lőw, Detlev Grabs, et al.. (1997). Synaptic Vesicle Endocytosis Impaired by Disruption of Dynamin-SH3 Domain Interactions. Science. 276(5310). 259–263. 405 indexed citations
6.
Grabs, Detlev, Vladimir I. Slepnev, Zhou Songyang, et al.. (1997). The SH3 Domain of Amphiphysin Binds the Proline-rich Domain of Dynamin at a Single Site That Defines a New SH3 Binding Consensus Sequence. Journal of Biological Chemistry. 272(20). 13419–13425. 211 indexed citations
7.
Butler, Margaret H., Carol David, Zachary Freyberg, et al.. (1997). Amphiphysin II (SH3P9; BIN1), a Member of the Amphiphysin/Rvs Family, Is Concentrated in the Cortical Cytomatrix of Axon Initial Segments and Nodes of Ranvier in Brain and around T Tubules in Skeletal Muscle. The Journal of Cell Biology. 137(6). 1355–1367. 205 indexed citations
8.
McPherson, Peter S., Elizabeth P. Garcia, Vladimir I. Slepnev, et al.. (1996). A presynaptic inositol-5-phosphatase. Nature. 379(6563). 353–357. 485 indexed citations
9.
David, Carol, Peter S. McPherson, Olaf Mundigl, & Pietro De Camilli. (1996). A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals.. Proceedings of the National Academy of Sciences. 93(1). 331–335. 350 indexed citations
10.
David, Carol, et al.. (1995). Molecular Mechanisms in Synaptic Vesicle Endocytosis. Cold Spring Harbor Symposia on Quantitative Biology. 60(0). 397–404. 4 indexed citations
11.
12.
Fishburn, C. Simone, et al.. (1994). The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain. FEBS Letters. 339(1-2). 63–66. 30 indexed citations
13.
Fishburn, C. Simone, et al.. (1994). In Vitro Translation of D2 Dopamine Receptors and Their Chimeras: Analysis by Subtype-Specific Antibodies. Biochemical and Biophysical Research Communications. 205(2). 1460–1466. 6 indexed citations
14.
David, Carol, C. Simone Fishburn, Frederick J. Monsma, David R. Sibley, & Sara Fuchs. (1993). Synthesis and processing of D2 dopamine receptors. Biochemistry. 32(32). 8179–8183. 19 indexed citations
15.
Fishburn, C. Simone, et al.. (1993). A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop.. Journal of Biological Chemistry. 268(8). 5872–5878. 75 indexed citations
16.
David, Carol & Sara Fuchs. (1991). Antipeptide Antibodies Localize N-(4-Azido-3-[125I] iodophenethyl)spiperone Binding to the Carboxyl-Terminal Portion of the D2 Dopamine Receptor. Molecular Pharmacology. 40(5). 712–716. 14 indexed citations
17.
David, Carol, Markus Ewert, P. H. Seeburg, & Sara Fuchs. (1991). Antipeptide antibodies differentiate between long and short isoforms of the D2 dopamine receptor. Biochemical and Biophysical Research Communications. 179(2). 824–829. 13 indexed citations
18.
Elazar, Zvulun, Hannah Kanety, Carol David, & Sara Fuchs. (1988). Purification of the D-2 dopamine receptor from bovine striatum. Biochemical and Biophysical Research Communications. 156(1). 602–609. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary A. Bittner Breakdown of academic impact, for papers by Yasuo Nemoto Breakdown of academic impact, for papers by Detlev Grabs Breakdown of academic impact, for papers by Bettina Winckler Breakdown of academic impact, for papers by M F Bader Breakdown of academic impact, for papers by Sergey V. Voronov Breakdown of academic impact, for papers by Lambert Edelmann Breakdown of academic impact, for papers by Francesca Navone Breakdown of academic impact, for papers by Mikhail Khvotchev Breakdown of academic impact, for papers by Phebe S. Wulf
Rankless by CCL
2026